Clinical study of Bibhitakyadi churna With Tablet Deriphylline in Asthma

An open labelled active control randomized clinical study to evaluate the efficacy of Bibhitakyadi churna With Tablet Deriphylline in Tamakshwasa

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030353

Enrollment

Registered

2021-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

Intervention1: Bibhitakyadi churna: 2 gm twice a day with anupan Madhu 7 days Control Intervention1: Tablet Deriphylline 150 mg : Twice a day with water 7 days

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 60 years Both male and female K/c/o Tamakswasa with symptoms Avegawastha

Exclusion criteria

Exclusion criteria: pregnant woman status Ashmaticus Cardiac Asthma Patients of Tamakswas with secondary infections Known case like Tuberculosis, Cor Pulmonale, Emphysema, Diabetes etc.

Design outcomes

Primary

Measure	Time frame
To show the efficacy of Bibhitakyadi Churna with tablet Deriphylline in TamakswasTimepoint: 7 days	—

Secondary

Measure	Time frame
To evaluate the efficacy of Bibhitakyadi churna in Tamakshwasa on the basis of pulomanry function test and peak flow meter.Timepoint: 7 days	—

Countries

India

Contacts

Public ContactDrMrunal Khilare

M.A.Ms Sumatibhai Shah Ayurved Mahavidyalaya

mrunalkhilare95@gmail.com7972844891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026